CCI: Approves Aspen’s proposition to acquire commercialization rights of Glaxo’s injectable anti-coagulants
Jan 25, 2017
|
Simply Register/Sign In to access the free content across the portals!
Not subscribed yet?
Gain access to unlimited paid content by subscribing to our portals